Cargando…
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
Cancer vaccination drives the generation of anti-tumor T cell immunity and can be enhanced by the inclusion of effective immune adjuvants such as type I interferons (IFNs). Whilst type I IFNs have been shown to promote cross-priming of T cells, the role of individual subtypes remains unclear. Here w...
Autores principales: | Audsley, Katherine M., Wagner, Teagan, Ta, Clara, Newnes, Hannah V., Buzzai, Anthony C., Barnes, Samantha A., Wylie, Ben, Armitage, Jesse, Kaisho, Tsuneyasu, Bosco, Anthony, McDonnell, Alison, Cruickshank, Mark, Fear, Vanessa S., Foley, Bree, Waithman, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450325/ https://www.ncbi.nlm.nih.gov/pubmed/34552594 http://dx.doi.org/10.3389/fimmu.2021.735133 |
Ejemplares similares
-
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
por: Buzzai, Anthony C., et al.
Publicado: (2020) -
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
por: Barrett, Lucy W, et al.
Publicado: (2022) -
Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
por: Armitage, Jesse D., et al.
Publicado: (2021) -
Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment
por: Newnes, Hannah V., et al.
Publicado: (2021) -
CD8(+)XCR1(neg) Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors
por: Wylie, Ben, et al.
Publicado: (2019)